Fourth Quarter 2025
Results compared to prior year period unless otherwise noted; does not include results for Husky Technologies
- Non-GAAP
Net Sales of$118 million , up 17% - GAAP Net Income of
$43 million , up 189% - Pro
Forma Adj . EBITDA of$43 million , up 41%, and ProForma Adj . EBITDA margin of 36.5%, up 640 basis points
Full Year 2025
Results compared to prior year period unless otherwise noted; does not include results for Husky Technologies
- Non-GAAP
Net Sales of$462 million , up 10% - GAAP Net Loss of
$136 million , down 48% - Pro
Forma Adj . EBITDA of$171 million , up 24%, and ProForma Adj . EBITDA margin of 36.9%, up 408 basis points
Recent Business Developments
- Completed business combination with Husky Technologies, rebranded to GPGI, completed debt refinancing to extend maturities and support future growth, and initiated a quarterly cash dividend
- Appointed Graham Robinson as President & CEO of
CompoSecure andRob Domodossola as President & CEO of Husky Technologies
Full Year 2026 Outlook
Following annual guidance is based upon expectations for the combined results of
- Pro
Forma Adj .Net Sales of$2,183 to$2,228 million - Pro
Forma Adj . EBITDA of$620 to$650 million - Pro
Forma Adj . Free Cash Flow of$325 to$375 million - Non-GAAP Year-end Net LTM Leverage less than 3.0x
Financial Results – Fourth Quarter and Full Year 2025 at

(1) All measures other than Net Income (Loss) / Adjusted Net Income (Loss), Pro Forma Adjusted EBITDA, and EPS / Adjusted EPS – Diluted are identical on a GAAP and non-GAAP basis, because such measures have historically been shown on a consolidated basis. (2) Pro Forma Adjusted EBITDA includes
Note on Accounting Treatment
As a result of the spin-off of
The GAAP results presented above for the fourth quarter and full year 2025 reflect the conversion to equity method accounting. For clarity of comparisons and to best reflect the financial results, the Company is also presenting the fourth quarter and full year 2025 on a consolidated basis consistent with historical presentation under the “Non-GAAP” headings.
Fourth Quarter and Full Year 2025 Earnings Conference Call
GPGI’s leadership team will discuss the Company’s results during a conference call on
Date:
Time:
Dial-in registration link: Here
Live webcast registration link: Here
About GPGI
About
Founded in 2000,
About Husky Technologies, a
Founded in 1953, Husky is a technology pioneer that enables the delivery of essential needs to the global community with industry-leading expertise and service. Husky is a leader in highly engineered equipment and aftermarket services. Husky’s products are used to manufacture a wide range of plastic products, including beverage and food containers, medical devices, and consumer electronic parts. Husky provides comprehensive and integrated systems solutions that are comprised of injection molding machines, molds, hot runners, controllers, and auxiliaries. For more information, please visit Husky.co.
Forward-Looking Statements
This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and assumptions of management. Although GPGI believes that its plans, intentions, and expectations reflected in or suggested by these forward-looking statements are reasonable, GPGI cannot assure you that it will achieve or realize these plans, intentions, or expectations. Forward-looking statements are inherently subject to risks, uncertainties, and assumptions. Generally, statements that are not historical facts, including but not limited to statements concerning GPGI’s possible or assumed future actions, business strategies, events, results of operations, demand, the implementation and anticipated impacts of the Resolute Operating System, guidance for 2026 and statements relating to growth, margin expansion, and free cash flow generation in 2026, are forward-looking statements. In some instances, these statements may be preceded by, followed by, or include the words “believes,” “estimates,” “expects,” “projects,” “outlook” “forecasts,” “may,” “will,” “should,” “seeks,” “plans,” “scheduled,” “anticipates” or “intends” or the negatives of these terms or variations of them or similar terminology. Forward-looking statements are not guarantees of performance. You should not put undue reliance on these statements which speak only as of the date hereof. You should understand that the following important factors, among others, could affect GPGI’s future results and could cause those results or other outcomes to differ materially from those expressed or implied in GPGI’s forward-looking statements: the ability of GPGI to grow and manage growth profitably, implement the Resolute Operating Sysstem successfully, maintain relationships with customers, compete within its industry and retain its key employees; the possibility that GPGI may be adversely impacted by global economic, business, competitive and/or other factors, including tariffs; the outcome of any legal proceedings that may be instituted against GPGI or others; future exchange and interest rates; changes in our accounting and/or financial presentation; anticipated demand for the products and services of GPGI’s businesses; the successful implementation of GPGI’s strategies; and other risks and uncertainties, including those under “Risk Factors” in filings that have been made or will be made with the Securities and Exchange Commission. GPGI undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Use of Non-GAAP Financial Measures
Due to the spin-off of
GPGI Contact
ir@gpgi.com
| Statements of Operations | |||||||||||||||
| Three Months Ended | |||||||||||||||
| ($ in thousands, except per share amounts) | |||||||||||||||
| (unaudited) | |||||||||||||||
| GAAP to Non-GAAP Operating Results | Three months ended | Three months ended December 31, 2024 | |||||||||||||
| GAAP | Equity Method Adjustments | Non-GAAP | Non- GAAP | ||||||||||||
| As Reported | Elimination of Equity Method Investment | Addition of Holdings | As Adjusted | As Reported | |||||||||||
| Net sales | $ | - | $ | - | $ | 117,709 | $ | 117,709 | $ | 100,859 | |||||
| Cost of sales | 2 | - | 52,171 | 52,173 | 48,325 | ||||||||||
| Gross profit | (2 | ) | - | 65,538 | 65,536 | 52,534 | |||||||||
| Operating expenses: | |||||||||||||||
| Selling, general and administrative expenses | 7,178 | 28,143 | 35,321 | 36,932 | |||||||||||
| Income from operations | (7,180 | ) | - | 37,395 | 30,215 | 15,602 | |||||||||
| Other expense | |||||||||||||||
| Revaluation of warrant liability | 1,824 | 1,824 | (19,726 | ) | |||||||||||
| Revaluation of earnout consideration liability | - | - | (42,245 | ) | |||||||||||
| Loss on remeasurement of TRA liability | (3,465 | ) | - | - | (3,465 | ) | - | ||||||||
| Interest expense | - | (2,284 | ) | (2,284 | ) | (902 | ) | ||||||||
| Interest income | 710 | 470 | 1,180 | 1,245 | |||||||||||
| Amortization of deferred financing costs | - | (166 | ) | (166 | ) | (196 | ) | ||||||||
| Total other expense | (931 | ) | - | (1,980 | ) | (2,911 | ) | (61,824 | ) | ||||||
| Income before income taxes | (8,111 | ) | - | 35,415 | 27,304 | (46,222 | ) | ||||||||
| Income tax expense | 16,020 | 16,020 | (2,136 | ) | |||||||||||
| Earnings in GPGI Holdings L.L.C equity method investment | 35,415 | (35,415 | ) | - | |||||||||||
| Net (loss) income | $ | 43,324 | $ | (35,415 | ) | $ | 35,415 | $ | 43,324 | $ | (48,358 | ) | |||
| Add: | |||||||||||||||
| Depreciation and amortization | 2,475 | 2,242 | |||||||||||||
| Income tax expense | (16,020 | ) | 2,136 | ||||||||||||
| Interest expense, net (1) | 1,270 | (147 | ) | ||||||||||||
| EBITDA | $ | 31,049 | $ | (44,127 | ) | ||||||||||
| All other changes | |||||||||||||||
| Stock-based compensation | 5,989 | 5,966 | |||||||||||||
| Mark to market adjustments (2) | (1,824 | ) | 61,971 | ||||||||||||
| Add back incurred Management Fees | 4,032 | - | |||||||||||||
| Loss on remeasurement of TRA liability | 3,465 | - | |||||||||||||
| Resolute spin off costs | - | 6,119 | |||||||||||||
| Additional earnout cost | - | 3,680 | |||||||||||||
| Husky transaction cost | 4,271 | - | |||||||||||||
| All other changes | $ | 15,933 | $ | 77,736 | |||||||||||
| Adjusted EBITDA | $ | 46,982 | $ | 33,609 | |||||||||||
| Add back expenses incurred on behalf of | - | ||||||||||||||
| Pro Forma full quarter Management Fee | (4,032 | ) | (3,253 | ) | |||||||||||
| Pro Forma Adjusted EBITDA | $ | 42,950 | $ | 30,356 | |||||||||||
Note: The Non-GAAP columns represent a consolidation of the Company’s results with those of
| Statements of Operations | |||||||||||||||
| Year Ended | |||||||||||||||
| ($ in thousands, except per share amounts)) | |||||||||||||||
| (unaudited) | |||||||||||||||
| GAAP to Non-GAAP Operating Results | Year ended | Year ended 2024 | |||||||||||||
| GAAP | Equity Method Adjustments | Non-GAAP | Non- GAAP | ||||||||||||
| As Reported | Elimination of Equity Method Investment | Addition of Holdings | As Adjusted | As Reported | |||||||||||
| Net sales | $ | 59,824 | $ | 402,231 | $ | 462,055 | $ | 420,571 | |||||||
| Cost of sales | $ | 31,077 | 170,767 | 201,844 | 201,344 | ||||||||||
| Gross profit | 28,747 | - | 231,464 | 260,211 | 219,227 | ||||||||||
| Operating expenses | |||||||||||||||
| Selling, general and administrative expenses | 42,478 | 95,612 | 138,090 | 111,605 | |||||||||||
| Income from operations | (13,731 | ) | - | 135,852 | 122,121 | 107,622 | |||||||||
| Other expense | |||||||||||||||
| Revaluation of warrant liability | (150,958 | ) | (150,958 | ) | (95,937 | ) | |||||||||
| Revaluation of earnout consideration liability | (57,101 | ) | (57,101 | ) | (76,305 | ) | |||||||||
| Change in fair value of derivative liability | - | - | 425 | ||||||||||||
| Loss on remeasurement of TRA liability | (3,465 | ) | (3,465 | ) | - | ||||||||||
| Interest expense | (1,688 | ) | (10,722 | ) | (12,410 | ) | (20,176 | ) | |||||||
| Interest income | 1,233 | 4,231 | 5,464 | 4,648 | |||||||||||
| Loss on extinguishment of debt | - | - | - | (148 | ) | ||||||||||
| Amortization of deferred financing costs | (74 | ) | (556 | ) | (630 | ) | (1,104 | ) | |||||||
| Total other expense | (212,053 | ) | - | (7,047 | ) | (219,100 | ) | (188,597 | ) | ||||||
| Income before income taxes | (225,784 | ) | - | 128,805 | (96,979 | ) | (80,975 | ) | |||||||
| Income tax expense | (39,026 | ) | (39,026 | ) | (2,187 | ) | |||||||||
| Earnings in GPGI Holdings L.L.C equity method investment | 128,805 | (128,805 | ) | - | - | - | |||||||||
| Net (loss) income | $ | (136,005 | ) | $ | (128,805 | ) | $ | 128,805 | $ | (136,005 | ) | $ | (83,162 | ) | |
| Add: | |||||||||||||||
| Depreciation and amortization | 9,377 | 9,174 | |||||||||||||
| Income tax expense | 39,026 | 2,187 | |||||||||||||
| Interest expense, net (1) | 7,576 | 16,780 | |||||||||||||
| EBITDA | $ | (80,026 | ) | $ | (55,021 | ) | |||||||||
| All other changes | |||||||||||||||
| Stock-based compensation | 22,777 | 21,235 | |||||||||||||
| Mark to market adjustments (2) | 208,059 | 171,817 | |||||||||||||
| Add back incurred Management Fees | 12,278 | - | |||||||||||||
| Secondary offering transaction costs | - | 586 | |||||||||||||
| Loss on remeasurement of TRA liability | 3,465 | - | |||||||||||||
| Resolute spin off costs | 5,452 | 6,119 | |||||||||||||
| Additional Earnout cost | 4,967 | 3,680 | |||||||||||||
| Tungsten Transaction cost | - | 2,726 | |||||||||||||
| Debt refinance costs | - | 225 | |||||||||||||
| Husky transaction cost | 7,077 | - | |||||||||||||
| All other changes | $ | 264,075 | $ | 206,388 | |||||||||||
| Adjusted EBITDA | $ | 184,049 | $ | 151,367 | |||||||||||
| Add back expenses incurred on behalf of | 979 | ||||||||||||||
| Pro Forma full year Management Fee | (14,323 | ) | (13,159 | ) | |||||||||||
| Pro Forma Adjusted EBITDA | $ | 170,705 | $ | 138,208 | |||||||||||
Note: The Non-GAAP columns represent a consolidation of the Company’s results with those of
| Balance Sheet | |||||||||
| ($ in thousands, except per share amounts) | |||||||||
| (unaudited) | |||||||||
| GAAP | Non GAAP | GAAP | |||||||
2025 | 2025 | 2024 | |||||||
| ASSETS | |||||||||
| CURRENT ASSETS | |||||||||
| Cash and cash equivalents | $ | 114,642 | $ | 271,601 | $ | 77,461 | |||
| Short-term investments | - | 41,076 | - | ||||||
| Accounts receivable | - | 44,220 | 47,449 | ||||||
| Inventories, net | - | 44,214 | 44,833 | ||||||
| Prepaid expenses and other current assets | 5,446 | 8,571 | 4,159 | ||||||
| Total current assets | 120,088 | 409,682 | 173,902 | ||||||
| Property and equipment, net and right of use asset | - | 30,701 | 28,852 | ||||||
| Deferred tax asset | 271,724 | 271,724 | 264,815 | ||||||
| Other assets | - | 4,004 | 6,349 | ||||||
| Equity method investment | 125,455 | - | - | ||||||
| Total assets | $ | 517,267 | $ | 716,111 | $ | 473,918 | |||
| LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | |||||||||
| CURRENT LIABILITIES | |||||||||
| Accounts payable | 922 | 12,736 | 11,544 | ||||||
| Accrued expenses | 1,851 | 48,724 | 25,711 | ||||||
| Current portion of long-term debt | - | 15,000 | 11,250 | ||||||
| Other current liabilities | 16,193 | 18,353 | 27,817 | ||||||
| Total current liabilities | 18,966 | 94,813 | 76,322 | ||||||
| Long-term debt, net of deferred finance costs | - | 169,791 | 184,389 | ||||||
| Warrant liability | - | - | 104,231 | ||||||
| Lease liabilities - operating leases | - | 7,352 | 3,888 | ||||||
| Tax receivable agreement liability | 255,160 | 255,160 | 248,534 | ||||||
| Total liabilities | 274,126 | 527,116 | 617,364 | ||||||
| Shareholders' equity (deficit) | 243,141 | 188,995 | (143,446 | ) | |||||
| Total liabilities and shareholder's equity (deficit) | $ | 517,267 | $ | 716,111 | $ | 473,918 | |||
| Note: The non-GAAP balance sheet represents a consolidation of the Company’s results with those of | |||||||||
| Consolidated Statements of Cash Flows | |||||||||||
| ($ in thousands) (unaudited) | |||||||||||
| Year Ended | |||||||||||
| 2025 | 2025 | 2024 | |||||||||
| As reported | Non GAAP | As reported | |||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||
| Net loss | $ | (136,005 | ) | $ | (136,005 | ) | $ | (83,162 | ) | ||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities | |||||||||||
| Depreciation and amortization | 1,623 | 9,377 | 9,174 | ||||||||
| Stock-based compensation expense | 4,468 | 22,777 | 21,235 | ||||||||
| Earnings in equity method investment | (128,805 | ) | - | - | |||||||
| Cash receipts from Holdings | 21,659 | - | - | ||||||||
| Loss on extinguishment of debt | - | - | 148 | ||||||||
| Non-cash interest | - | (1,076 | ) | - | |||||||
| Amortization of deferred finance costs | 74 | 632 | 1,155 | ||||||||
| Revaluation of earnout consideration liability | 57,101 | 57,101 | 76,305 | ||||||||
| Revaluation of warrant liability | 150,958 | 150,958 | 95,937 | ||||||||
| Loss on remeasurement of TRA Liability | 3,465 | 3,465 | - | ||||||||
| Change in fair value of derivative liability | - | - | (425 | ) | |||||||
| Deferred tax expense | 14,743 | 14,743 | (2,469 | ) | |||||||
| Changes in assets and liabilities | (12,163 | ) | 23,665 | 11,655 | |||||||
| Net cash (used in) provided by operating activities | (22,882 | ) | 145,637 | 129,553 | |||||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||||
| Purchase of property and equipment | - | (6,857 | ) | (7,410 | ) | ||||||
| Purchase of treasury bills | - | (40,000 | ) | - | |||||||
| Holdings cash deconsolidated as a result of the Management Agreement | (50,303 | ) | - | - | |||||||
| (10,000 | ) | - | - | ||||||||
| Investment in SAFE | (1,500 | ) | |||||||||
| Capitalized software expenditures | (387 | ) | (1,507 | ) | (1,035 | ) | |||||
| Net cash used in investing activities | (60,690 | ) | (48,364 | ) | (9,945 | ) | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||||
| Proceeds from employee stock purchase plan and exercise of options | 121 | 871 | 4,998 | ||||||||
| Payments for taxes related to net share settlement of equity awards and earnout liability | (18,011 | ) | (21,389 | ) | (12,783 | ) | |||||
| Payment of term loan | - | (11,250 | ) | (12,813 | ) | ||||||
| Payment of tax receivable agreement liability | (5,305 | ) | (5,305 | ) | (1,303 | ) | |||||
| Purchase of treasury shares | (12,247 | ) | (12,247 | ) | - | ||||||
| Deferred finance costs related to debt modification | - | - | (2,104 | ) | |||||||
| Contribution to | - | (10,008 | ) | - | |||||||
| Distributions to non-controlling interest | - | - | (34,863 | ) | |||||||
| Special distribution to non-controlling interest | - | - | (15,573 | ) | |||||||
| Dividend to Class A shareholders | - | - | (8,922 | ) | |||||||
| Proceeds from the exercise of warrants | 156,195 | 156,195 | - | ||||||||
| Net cash provided by (used in) financing activities | 120,753 | 96,867 | (83,363 | ) | |||||||
| Net increase in cash and cash equivalents | 37,181 | 194,140 | 36,245 | ||||||||
| Cash and cash equivalents, beginning of period | 77,461 | 77,461 | 41,216 | ||||||||
| Cash and cash equivalents, end of period | $ | 114,642 | $ | 271,601 | $ | 77,461 | |||||
| Supplementary disclosure of cash flow information | |||||||||||
| Cash paid for interest | 2,164 | 12,758 | 20,608 | ||||||||
| Cash paid for income taxes | 24,310 | 24,310 | 4,820 | ||||||||
| Supplemental disclosure of non-cash financing activity: | |||||||||||
| Operating lease ROU assets exchanged for lease liabilities | 4,224 | 5,489 | - | ||||||||
| Revaluation of derivative asset - interest rate swap | (502 | ) | (2,749 | ) | (2,448 | ) | |||||
| Non-cash portion of warrant exercise | (255,189 | ) | (255,189 | ) | - | ||||||
| Settlement of earnout | (77,634 | ) | (77,634 | ) | (56,625 | ) | |||||
| Contribution to Holdings for share-based compensation | 18,309 | - | - | ||||||||
| Holdings net liabilities, excluding cash and cash equivalent, deconsolidated as a result of Management Agreement | (100,378 | ) | - | - | |||||||
| (1,542 | ) | - | - | ||||||||
| Note: The Non-GAAP | |||||||||||
| Adjusted Net Income and Earnings Per Share: Non-GAAP Reconciliation | |||||||||||||
| Basic | |||||||||||||
| Three Months Ended | Year Ended | ||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||
| (in thousands, except per share data) | |||||||||||||
| Net (loss) income | $ | 43,324 | $ | (48,358 | ) | $ | (136,005 | ) | $ | (83,162 | ) | ||
| Add (less): Provision (benefit) for income taxes | (16,020 | ) | 2,136 | 39,026 | 2,187 | ||||||||
| Add (less): Mark-to-market adjustments (1) | (1,824 | ) | 61,971 | 208,059 | 171,817 | ||||||||
| Add: stock-based compensation | 5,989 | 5,966 | 22,777 | 21,235 | |||||||||
| Less: Proforma Management Fees | - | (3,253 | ) | (2,045 | ) | (13,159 | ) | ||||||
| Add: Husky transaction costs | 4,271 | 7,077 | - | ||||||||||
| Add: Loss on remeasurement of TRA Liability | 3,465 | - | 3,465 | - | |||||||||
| Add: secondary offering transaction costs | - | - | - | 586 | |||||||||
| Add: Tungsten Transaction costs | - | - | - | 2,726 | |||||||||
| Add: Debt refinance costs | - | - | - | 225 | |||||||||
| Add: Additional earnout cost | - | 3,680 | 4,967 | 3,680 | |||||||||
| Add: Spin-Off costs | - | 6,119 | 5,452 | 6,119 | |||||||||
| Adjusted net income before tax | 39,205 | 28,261 | 152,773 | 112,254 | |||||||||
| Income tax expense (2) | 8,617 | 6,138 | 33,580 | 24,382 | |||||||||
| Adjusted net income | 30,588 | 22,123 | 119,193 | 87,872 | |||||||||
| Common shares outstanding used in computing net income per share, basic: | |||||||||||||
| Class A common shares | 126,057 | 91,371 | 110,517 | 83,834 | |||||||||
| Adjusted net income per share - basic | $ | 0.24 | $ | 0.24 | $ | 1.08 | $ | 1.05 | |||||
| Diluted | |||||||||||||
| Three Months Ended | Year Ended | ||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||
| (in thousands, except per share data) | |||||||||||||
| Adjusted net income | $ | 30,588 | $ | 22,123 | $ | 119,193 | $ | 87,872 | |||||
| Add: Interest on Exchangeable Notes net of tax (4) | - | (2,110 | ) | - | 3,238 | ||||||||
| Adjusted net income used in computing net income per share, diluted | 30,588 | 20,013 | 119,193 | 91,110 | |||||||||
| Common shares outstanding used in computing earnings per share, diluted: | 126,057 | 91,371 | 110,517 | 83,834 | |||||||||
| Warrants (3) | 1,355 | 8,094 | 5,715 | 8,094 | |||||||||
| Exchangeable notes (4) | - | 5,795 | - | 11,629 | |||||||||
| Equity awards | 6,568 | 4,901 | 4,728 | 3,411 | |||||||||
| Total shares outstanding used in computing adjusted earnings per share - Diluted | 133,980 | 110,161 | 120,960 | 106,968 | |||||||||
| Adjusted net income per share - Diluted | $ | 0.23 | $ | 0.18 | $ | 0.99 | $ | 0.85 | |||||
(1) Includes the changes in fair value of warrant liability, make-whole provision of the previously outstanding exchangeable notes of
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3b7e844a-4e9e-4a8d-9f7e-11c6f40fc258

